• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消化性溃疡疾病中强效与轻度抑酸治疗的比较

Potent versus mild acid suppression in peptic ulcer disease.

作者信息

Howden C W

机构信息

University of South Carolina, Columbia.

出版信息

Hepatogastroenterology. 1992 Feb;39 Suppl 1:45-6.

PMID:1349552
Abstract

In the consideration of potent versus mild suppression of gastric acid secretion in the treatment of peptic ulcer disease, it must be remembered that pharmacological effect in terms of degree of suppression of acidity is closely linked to therapeutic efficacy in terms of numbers of ulcers healed. More potent degrees of suppression of acidity result in faster ulcer healing. Moderate suppression of acidity, such as is achieved by the H2RA, can heal just as many ulcers if treatment is continued longer. Mild acid suppression will take still longer to produce the same healing rates. Therapeutic benefit of any treatment must be assessed also in terms of the side-effect profile of the drug or drugs used. There is an enormous cumulative experience with the H2RA as a group and they are known to have an excellent safety profile.

摘要

在考虑强力抑制胃酸分泌与轻度抑制胃酸分泌在消化性溃疡疾病治疗中的作用时,必须记住,就胃酸抑制程度而言的药理作用与就愈合溃疡数量而言的治疗效果密切相关。更强程度的胃酸抑制会导致溃疡愈合更快。适度抑制胃酸,如使用H2受体拮抗剂所达到的效果,如果持续更长时间治疗,也能愈合同样数量的溃疡。轻度胃酸抑制则需要更长时间才能达到相同的愈合率。任何治疗的治疗益处还必须根据所用药物的副作用情况来评估。作为一个药物类别,H2受体拮抗剂有大量的累积经验,并且已知它们具有出色的安全性。

相似文献

1
Potent versus mild acid suppression in peptic ulcer disease.消化性溃疡疾病中强效与轻度抑酸治疗的比较
Hepatogastroenterology. 1992 Feb;39 Suppl 1:45-6.
2
Drugs for treatment of peptic ulcers.治疗消化性溃疡的药物。
J Assoc Acad Minor Phys. 1992;3(3):78-88.
3
Recent advances in the treatment of digestive diseases.消化系统疾病治疗的最新进展。
J Int Med Res. 1989;17 Suppl 1:2A-8A.
4
Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.执业医师使用H2受体拮抗剂和质子泵抑制剂的药理学及药效学要点
Best Pract Res Clin Gastroenterol. 2001 Jun;15(3):355-70. doi: 10.1053/bega.2001.0184.
5
Current concepts in clinical therapeutics: peptic ulcer disease.临床治疗学的当前概念:消化性溃疡病
Clin Pharm. 1986 Feb;5(2):128-42.
6
Medical treatment of peptic ulcers.消化性溃疡的医学治疗。
Surg Annu. 1985;17:219-33.
7
Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
Ital J Gastroenterol. 1990;22 Suppl 1:2-4.
8
Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.胃酸分泌的控制。组胺H2受体拮抗剂和H⁺K⁺-ATP酶抑制剂。
Gastroenterol Clin North Am. 1992 Sep;21(3):527-50.
9
Pharmacologic options for the control of peptic ulcer disease.控制消化性溃疡疾病的药物治疗选择。
Adv Intern Med. 1984;30:425-47.
10
Overview of medical therapy of peptic ulcer disease.消化性溃疡疾病的药物治疗概述
Gastroenterol Clin North Am. 1990 Mar;19(1):121-40.